Summary
DexCom, Inc. (DXCM) reported its financial results for the second quarter and the first half of 2015. The company demonstrated significant revenue growth, with product revenue increasing by approximately 59% year-over-year for the quarter and 58% for the first half. This growth was primarily driven by increased sales volume of their G4 PLATINUM continuous glucose monitoring (CGM) system, particularly disposable sensors. Despite the strong revenue performance, the company continued to operate at a net loss, though the loss narrowed on a per-share basis. Significant investments in research and development, along with increased selling, general, and administrative expenses, contributed to the ongoing net loss. The company maintains a solid liquidity position with approximately $97.5 million in cash, cash equivalents, and marketable securities as of June 30, 2015, and projects sufficient funds to operate through at least June 30, 2016. Management is focused on scaling manufacturing and expanding commercialization efforts, highlighting the growing installed base of customers using their G4 PLATINUM system and the recent launch of the G4 PLATINUM with Share remote monitoring system. Investors should monitor the company's progress in achieving profitability while continuing to expand market share and develop new product iterations.
Financial Highlights
48 data points| Revenue | $92.90M |
| Cost of Revenue | $27.20M |
| Gross Profit | $66.00M |
| R&D Expenses | $24.40M |
| SG&A Expenses | $45.20M |
| Operating Expenses | $69.60M |
| Operating Income | -$3.60M |
| Interest Expense | $100K |
| Net Income | -$3.70M |
| Shares Outstanding (Basic) | 318.40M |
| Shares Outstanding (Diluted) | 318.40M |
Key Highlights
- 1Product revenue significantly increased by 59% to $92.9 million for the three months ended June 30, 2015, compared to $58.2 million in the prior year period.
- 2Gross profit grew by 66% to $65.7 million for the quarter, reflecting strong revenue growth and improved gross margins.
- 3Despite revenue growth, the company reported a net loss of $3.7 million for the quarter, a reduction from $6.0 million in the prior year period.
- 4Operating expenses, particularly Research & Development and Selling, General & Administrative, saw substantial increases, indicating continued investment in growth and product development.
- 5Cash, cash equivalents, and marketable securities stood at $97.5 million as of June 30, 2015, providing a healthy liquidity position.
- 6The company successfully launched the G4 PLATINUM with Share remote monitoring system in Q1 2015, enhancing product offerings.
- 7Inventory levels increased to $22.4 million from $16.0 million, reflecting preparations for increased sales volume and potential new product launches.